Xingtai Jiachuang Technology Tesamorelin
As of 9 Aug 2026, Finnrick has published 10 independent lab tests of Tesamorelin from Xingtai Jiachuang Technology: 3 passed and 7 failed under the default public standard, Purity Focus (HPLC purity at least 99.5%, fill within ±35% of the label claim). The latest test is dated 13 Jul 2026. The current Finnrick rating for Xingtai Jiachuang Technology Tesamorelin is 39%.
Finnrick ratings are recency-weighted pass percentages: newer tests count more, and vendors with thin test histories are pulled toward the peer baseline for that peptide, so a single result cannot look too certain. Samples are analyzed by independent partner laboratories and the results are published by Finnrick Analytics, which does not sell peptides and does not accept payment to alter ratings. Corrections to published data are recorded at finnrick.com/corrections.
Interactive charts, prices, and test history for this page load with JavaScript; the facts above are from Finnrick's published test database.
| Date | Result | Certificate |
|---|---|---|
| 13 Jul 2026 | Fail | Certificate 5q5h4pk |
| 17 Jun 2026 | Fail | Certificate x7afvdw |
| 20 Feb 2026 | Fail | Certificate yym2aqn |
| 9 Feb 2026 | Fail | Certificate 4yefevh |
| 29 Jan 2026 | Pass | Certificate pwc7exm |
| 19 Jan 2026 | Pass | Certificate pftw4mv |
| 15 Jan 2026 | Fail | Certificate huj9jub |
| 6 Jan 2026 | Pass | Certificate 62fe37q |
| 6 Jan 2026 | Fail | Certificate 5qr2ncb |
| 4 Nov 2025 | Fail | Certificate 8vc82yp |